Literature DB >> 18703501

Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes.

Mika Hilvo1, Lina Baranauskiene, Anna Maria Salzano, Andrea Scaloni, Daumantas Matulis, Alessio Innocenti, Andrea Scozzafava, Simona Maria Monti, Anna Di Fiore, Giuseppina De Simone, Mikaela Lindfors, Janne Jänis, Jarkko Valjakka, Silvia Pastoreková, Jaromir Pastorek, Markku S Kulomaa, Henri R Nordlund, Claudiu T Supuran, Seppo Parkkila.   

Abstract

Carbonic anhydrase IX (CA IX) is an exceptional member of the CA protein family; in addition to its classical role in pH regulation, it has also been proposed to participate in cell proliferation, cell adhesion, and tumorigenic processes. To characterize the biochemical properties of this membrane protein, two soluble recombinant forms were produced using the baculovirus-insect cell expression system. The recombinant proteins consisted of either the CA IX catalytic domain only (CA form) or the extracellular domain, which included both the proteoglycan and catalytic domains (PG + CA form). The produced proteins lacked the small transmembrane and intracytoplasmic regions of CA IX. Stopped-flow spectrophotometry experiments on both proteins demonstrated that in the excess of certain metal ions the PG + CA form exhibited the highest catalytic activity ever measured for any CA isozyme. Investigations on the oligomerization and stability of the enzymes revealed that both recombinant proteins form dimers that are stabilized by intermolecular disulfide bond(s). Mass spectrometry experiments showed that CA IX contains an intramolecular disulfide bridge (Cys(119)-Cys(299)) and a unique N-linked glycosylation site (Asn(309)) that bears high mannose-type glycan structures. Parallel experiments on a recombinant protein obtained by a mammalian cell expression system demonstrated the occurrence of an additional O-linked glycosylation site (Thr(78)) and characterized the nature of the oligosaccharide structures. This study provides novel information on the biochemical properties of CA IX and may help characterize the various cellular and pathophysiological processes in which this unique enzyme is involved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703501     DOI: 10.1074/jbc.M800938200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells.

Authors:  Ying Li; Hai Wang; Chingkuang Tu; Kathleen T Shiverick; David N Silverman; Susan C Frost
Journal:  Biochim Biophys Acta       Date:  2010-10-12

2.  The Structure of Carbonic Anhydrase IX Is Adapted for Low-pH Catalysis.

Authors:  Brian P Mahon; Avni Bhatt; Lilien Socorro; Jenna M Driscoll; Cynthia Okoh; Carrie L Lomelino; Mam Y Mboge; Justin J Kurian; Chingkuang Tu; Mavis Agbandje-McKenna; Susan C Frost; Robert McKenna
Journal:  Biochemistry       Date:  2016-08-05       Impact factor: 3.162

3.  Sweet Binders: Carbonic Anhydrase IX in Complex with Sucralose.

Authors:  Carrie L Lomelino; Akilah B Murray; Claudiu T Supuran; Robert McKenna
Journal:  ACS Med Chem Lett       Date:  2018-05-10       Impact factor: 4.345

4.  Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.

Authors:  Caroli Genis; Katherine H Sippel; Nicolette Case; Wengang Cao; Balendu Sankara Avvaru; Lawrence J Tartaglia; Lakshmanan Govindasamy; Chingkuang Tu; Mavis Agbandje-McKenna; David N Silverman; Charles J Rosser; Robert McKenna
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

5.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

Review 6.  Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.

Authors:  Emma Langella; Martina Buonanno; Giuseppina De Simone; Simona Maria Monti
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

7.  The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis.

Authors:  Kristiina Nordfors; Joonas Haapasalo; Miikka Korja; Anssi Niemelä; Jukka Laine; Anna-Kaisa Parkkila; Silvia Pastorekova; Jaromir Pastorek; Abdul Waheed; William S Sly; Seppo Parkkila; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-04-18       Impact factor: 4.430

8.  Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology.

Authors:  Chen Xu; Agnes Lo; Anuradha Yammanuru; Aimee St Clair Tallarico; Kristen Brady; Akikazu Murakami; Natasha Barteneva; Quan Zhu; Wayne A Marasco
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.

Authors:  M Ilie; N M Mazure; V Hofman; R E Ammadi; C Ortholan; C Bonnetaud; K Havet; N Venissac; B Mograbi; J Mouroux; J Pouysségur; P Hofman
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

10.  Global transcriptional response to carbonic anhydrase IX deficiency in the mouse stomach.

Authors:  Heini Kallio; Mika Hilvo; Alejandra Rodriguez; Eeva-Helena Lappalainen; Anna-Maria Lappalainen; Seppo Parkkila
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.